Latin America Point of Care (POC) Diagnostics/Testing Market Research Report – Segmented By Product, End-User, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis From 2026 to 2034
The Latin America point of care (POC) diagnostics/testing market size was valued at USD 3.26 billion in 2025 and is anticipated to reach USD 3.58 billion in 2026 from USD 7.50 billion by 2034, growing at a CAGR of 9.68% during the forecast period from 2026 to 2034.
The introduction of cost-effective technologies related to the efficient and accurate detection, diagnosis, and surveillance of disease and government initiatives to control the spread of disease and provide better health facilities, will serve as an essential factor in the course of the forecast period. Besides, the increase in the geriatric population, which is more prone to infections and other diseases, is expected to stimulate demand for home health care and independent living diagnostic and monitoring devices. Besides, adoption of a sedentary lifestyle by the young and middle-aged population is believed to contribute to the prevalence of diabetes, heart problems, drug addiction, and STDs in developing countries, in addition to the expected prevalence presence of chronic and endemic diseases such as Chagas in less developed regions to increase market potential. Increasingly concerned about the increasing prevalence of infectious diseases in Latin America, several health organizations and governments have put detection programs and plans to control and eradicate these diseases. Gradually growing economies, increasing the purchasing power of the population, high prevalence of the disease, and increased awareness of medicine are expected to push the point-of-care diagnostics market in Latin America in the forecast period.
The high price of molecular test kits is expected to hamper the growth of the market. Molecular-based test kits play an essential role in the diagnosis of infectious diseases. However, the high price of molecular test kits leads to their low adoption, especially in emerging countries. The non-reimbursement of certain infectious diseases is also expected to limit the growth of the market.
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 9.68% |
| Segments Covered | By Product, End user and Region. |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Country Covered | Brazil, Mexico, Argentina, Chile, and the Rest of Latin America. |
| Market Leaders Profiled | Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics. |
Regionally, emerging markets such as Brazil offer high growth potential for companies involved in developing and distributing point-of-care diagnostic devices. Increasing initiatives by market players, a growing patient population base, and a rise in the number of partnerships and joint ventures among point-of-care providers are the key factors driving the growth of the point-of-care diagnostics market in emerging countries.
The Latin American region has suffered a significant epidemiological burden of infectious diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, Zika, and COVID-19 in recent years. The increasing prevalence of several infectious diseases in low-economy countries like Haiti, Bolivia, Guatemala, and others and the rapid spread of STDs in the developing economies of Brazil, Mexico, and Chile, should stimulate the need for POC Diagnostics superior to the prognosis period. Besides, the number of government initiatives for early detection and diagnosis of the disease and support for establishing health check-ups and camps is expected to increase demand. Brazil dominated the POC diagnostics industry in Latin America in 2019, with an estimated revenue share of over 41%. The presence of healthcare reforms, such as the Unified Healthcare System, is expected to boost the market growth in Brazil. The high prevalence of infections and the rapid increase in diabetes, cancer, and heart conditions in the country are expected to increase POC diagnostics demand. Chile is estimated to experience potential development in the coming years due to the emergence of the Zika virus and a greater prevalence of Chagas disease. The evolution of the economy to develop the health care infrastructure, control and reduce the incidence of target diseases, and prevent the emergence of new diseases, is estimated to boost the demand for POC diagnostics in this country.
Some of the Key players dominating the Latin American POC testing market include
This market research report on the Latin America POC Diagnostics Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024 have been analyzed.
By Product
By End-User
By Country
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region